| abstract |
The present disclosure provides dimers formed from two polypeptide chains, wherein each of the two polypeptide chains comprises an antibody Fc subunit, wherein the dimer comprises two or more immunoglobulin monomers Variable domains (ISVDs), at least one of which is capable of specifically binding PD-L1 and at least one of which is capable of specifically binding CTLA4. |